Literature DB >> 7792798

Adrenal steroids and cardiac fibrosis.

M Young1.   

Abstract

Uninephrectomized rats maintained on 0.9% NaCl as drinking fluid and infused for 8 weeks with aldosterone 0.75 micrograms/h via subcutaneous osmotic minipumps respond with hypertension, cardiac hypertrophy, and both interstitial and perivascular cardiac fibrosis. Similar animals injected with desoxycorticosterone (20 mg/week), or the glucocorticoid antagonist RU 486 (2 mg/day) show interstitial cardiac fibrosis to a lesser degree than animals injected with aldosterone, and show perivascular fibrosis to a greater degree. These findings suggest that glucocorticoid antagonist activity may play a role in exacerbating perivascular collagen deposition in response to chronic mineralocorticoid and salt imbalance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7792798     DOI: 10.1016/0039-128x(94)00029-c

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  3 in total

1.  Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex.

Authors:  Hirochika Kitagawa; Junn Yanagisawa; Hiroaki Fuse; Satoko Ogawa; Yoshiko Yogiashi; Atsuro Okuno; Hiromichi Nagasawa; Toshihiro Nakajima; Toshio Matsumoto; Shigeaki Kato
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Inhibition of tissue repair by spironolactone: role of mineralocorticoids in fibrous tissue formation.

Authors:  S H Slight; V K Chilakamarri; S Nasr; A K Dhalla; F J Ramires; Y Sun; V K Ganjam; K T Weber
Journal:  Mol Cell Biochem       Date:  1998-12       Impact factor: 3.396

Review 3.  Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis.

Authors:  Greg H Tesch; Morag J Young
Journal:  Front Pharmacol       Date:  2017-05-29       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.